Question 1

What specific benefits do you think cabozantinib and pembrolizumab could offer me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cabozantinib and Pembrolizumab in Metastatic Pancreas clinical trial (NCT05052723). Contact the study team or your healthcare provider for specific answers.

Question 2

How do these drugs compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cabozantinib and Pembrolizumab in Metastatic Pancreas clinical trial (NCT05052723). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cabozantinib and Pembrolizumab in Metastatic Pancreas clinical trial (NCT05052723). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cabozantinib and Pembrolizumab in Metastatic Pancreas clinical trial (NCT05052723). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cabozantinib and Pembrolizumab in Metastatic Pancreas clinical trial (NCT05052723). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Cabozantinib and Pembrolizumab in Metastatic Pancreas clinical trial (NCT05052723). Contact the study team or your healthcare provider for specific answers.

What this study is about